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ABSTRACT
Objective: Type 2 diabetes mellitus (T2DM) patients tend to have abnormal lipid profiles, explaining the association between elevated cholesterol and 
triglyceride levels in diabetic patients and coronary heart disease. This study aims to evaluate how the common risk factors for dyslipidemia affect 
the lipid profile of diabetic patients and to determine which factors can be used as predictors for the occurrence of dyslipidemia in T2DM patients.
Methods: A total of 238 diabetic patients (63 male and 175 female; age: 31–70 years) were enrolled in this cross-sectional study. All of them had 
undergone regular examinations in cohort studies on risk factors for non-communicable diseases conducted by the Ministry of Health in Bogor 
between December 2017 and January 2018.
Results: The result found that age differences did not affect lipid profile levels, and the females had higher mean values of body mass index (p<0.001), 
total cholesterol (TC) (p<0.05), and high-density lipoprotein (HDL) (p<0.001) than the males. The most common occurrences of dyslipidemia were 
high TC level (57.1%), followed by high low-density lipoprotein (LDL) level (47.1%), high triglyceride level (37.4%), and low HDL level (16.4%). Being 
overweight was found to be the best predictor of dyslipidemia.
Conclusion: The results of this study suggest that in T2DM patients, sex affects TC and HDL levels, whereas age does not exert a significant effect on 
the lipid profiles. In addition, poor glycemic control, hypertension, and obesity may serve as predictors of dyslipidemia in T2DM patients.
Keywords: Type 2 diabetes, Dyslipidemia, Cardiovascular disease.
INTRODUCTION
Diabetes has become a global concern due to its increasing incidence. 
The number of patients with diabetics is expected to increase from 425 
million in 2017 to 693 million by 2045. The leading cause of morbidity 
and mortality for patients with type 2 diabetes mellitus (T2DM) is 
cardiovascular diseases (CVDs) [1]. T2DM is associated with an increased 
risk of macrovascular diseases such as atherosclerosis, coronary heart 
disease, and peripheral arterial disease [2]. Independently, diabetes 
may bring about a two-fold increase in the risk of macrovascular 
disease [3] as well as increase the effects of other risk factors that 
cause macrovascular diseases such as smoking, hypertension, and 
hypercholesterolemia [4]. The mortality rate associated with vascular 
abnormalities in people with diabetes mellitus is significantly higher 
than that of nondiabetic individuals [5]. According to the American 
Heart Association, at least 68% of the people with diabetes aged 
>65 years die of heart disease, whereas 16% die of stroke [6]. The 
overall cardiometabolic risk of diabetes is driven by a complex 
interplay between several non-modifiable (age, sex, and genetics) and 
modifiable (hypertension, hyperlipidemia, and hyperglycemia) factors 
and the components of the metabolic syndrome commonly associated 
with type 2 diabetes [1]. Therefore, patients with T2DM tend to have 
abnormal lipid profiles, which include increased total cholesterol 
(TC), increased cholesterol low-density lipoprotein (LDL), increased 
triglyceride (TG), and decreased cholesterol high-density lipoprotein 
(HDL) [7]. This explains the association between coronary heart disease 
and elevated cholesterol and triglyceride levels observed in patients 
with diabetes [2,8]. The impairment of sugar metabolism that occurs in 
patients with T2DM is strongly associated with impaired fat metabolism. 
Several known factors that contribute to this include insulin deficiency 
or resistance, adipocytokines, and hyperglycemia [9].
Indonesia has a high prevalence of diabetes. In 2015, it was the 7th country 
with the highest T2DM prevalence in the world with a 6% prevalence rate 
of diabetes-associated deaths. Although dyslipidemia plays an underlying 
role in diabetes, how its incidence is influenced by other risk factors is 
not widely known. Rather, unique genetic, cultural, and environmental 
factors shape the geographic patterns [10]. According to the WHO, the 
overall prevalence of dyslipidemia in Indonesia in 25-year-old adults 
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Age 53.56±9.11 52.85±9.15 0.527
Body weight (kg) 66.90±11.05 63.28±12.40 0.022*




2-h plasma glucose 
(mg/dL)
207.12±105.80 228.28±103.23 0.061
HbA1c (%) 7.20±2.33 6.80±2.40 0.055
Systole (mmHg) 141.61±23.48 139.29±21.62 0.479
Diastole (mmHg) 88.68±11.91 88.12±12.94 0.734
*p<0.05
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is around 35.8% [11]. It is against this background that this study was 
conducted to examine how the common risk factors for dyslipidemia 
affect the lipid profile of patients with diabetes and determine which of 
these factors can serve as the best predictors of its occurrence in T2DM.
MATERIALS AND METHODS
This study is a cross-sectional study. We analyzed the database of 
cohort studies on risk factors for non-communicable diseases carried 
out by the Ministry of Health in Bogor. This study was approved by the 
Ethical Committee of the Faculty of Medicine, Universitas Indonesia, and 
informed consent was obtained from each participant. We collected data 
on 238 diabetes subjects (31–70 years old) who had received regular 
examinations in the Ministry of Health cohort study. The data were 
obtained between December 2017 and January 2018. The diagnosis of 
diabetes was based on the criteria of the American Diabetes Association 
as follows: Glycosylated hemoglobin (HbA1c) level ≥6.5%, or a fasting 
plasma glucose (FPG) level ≥126 mg/dL, or a 2-h plasma glucose level 
≥200 mg/dL during a 75-g oral glucose tolerance test (OGTT), or a 
random plasma glucose ≥200 mg/dL in patients with classic symptoms 
of hyperglycemia (i.e., polyuria, polydipsia, polyphagia, and weight loss) 
or hyperglycemic crisis. Dyslipidemia was defined as a TC level ≥200 mg/
dL, or a triglyceride level ≥150 mg/dL, or a low-density lipoprotein 
cholesterol (LDL-C) ≥130 mg/dL, or a high-density lipoprotein cholesterol 
(HDL-C) ≤40 mg/dL. Poor glycemic control was defined as HbA1c >7%. 
Hypertension was defined as taking antihypertensive medications or 
having a systolic blood pressure (BP) of ≥140 mmHg and/or a diastolic 
BP of ≥90 mmHg. Overweight was defined as body mass index (BMI) ≥25.
We compared the mean lipid profile data based on sex and the age 
groups 30–39, 40–49, 50–59, and ≥60. The mean significance test for 
the age groups was done by ANOVA for normally distributed data and 
the Kruskal–Wallis test for data that are not normally distributed. The 
t-test was used to evaluate the sex group for normally distributed data 
and the Mann–Whitney test for data that are not normally distributed. 
We calculated the odds ratios (ORs) for poor glycemic control, 
hypertension, and overweight by dyslipidemia on each lipid profile 
(high TC, high TG, high LDL-C, and low HDL-C). Differences with a 
p<0.05 were considered statistically significant. All statistical analyses 
were performed using the SPSS Statistics software (IBM SPSS Statistics 
version 24 for Windows; IBM, New York, NY, USA).
RESULTS AND DISCUSSION
Subject characteristics
The characteristics of the 238 subjects were divided into male and 
female sex groups as shown in Table 1. There were no significant 
differences in the characteristics in terms of age, FPG, 2-h PG, HbA1c, 
and the systolic and diastolic BPs between the male and female groups. 
However, significant differences were seen in the body weight and BMI, 
the latter being higher in the females. Although both were significantly 
different, the BMI levels in both groups fall into the overweight category.
Lipid profile characteristic based on age and sex
The lipid profiles were stratified in terms of age group and sex. The 
results in Table 2 showed that there were no statistically significant 
lipid level differences within each age group. In terms of sex, there were 
statistically significant differences in TC and HDL level (Table 3). The 
mean TC in the female group was higher than the male group (p=0.039) 
while the mean HDL in the female group was also higher compared to 
the male group (p=0.000).
Pattern of dyslipidemia in study subjects
The prevalence of dyslipidemia in terms of TC, TG, LDL, and HDL 
showed that the most elevated indices of dyslipidemia were high TC 
levels (57.1%), followed by high LDL levels (47.1%), high TG levels 
(37.4%), and low HDL levels (16.4%). In terms of the pattern of 
dyslipidemia, subjects with two types of lipid abnormalities were the 
highest (35.3%), followed by three types of abnormalities (21.0%), one 
type of abnormality (26.9), and all four types of abnormalities (2.5%). 
The number of subjects who did not have lipid abnormalities was 
64 (26.9%).
Dyslipidemia risk factor
Table 4 showed that being overweight increased the risk of dyslipidemia 
in the form of abnormalities in the level of TC, TG, and LDL. In addition, 
being hypertensive increased the risk of abnormalities in the level of TC 
and LDL. The least predictor of dyslipidemia was poor glycemic control, 
which increased the risk of abnormalities only in the level of TG.
DISCUSSION
An examination of the biomedical parameters of the diabetes subjects 
in this study showed that there were no statistical differences in the 
glycemic characteristics of FPG, OGTT, and HbA1c between the male and 
female groups. In line with the results of this study, studies in Turkey, 
in patients at a high risk for diabetes in the US, and in cynomolgus 
monkeys with impaired FPG, indicate that sex is not associated with 
FPG level [12-14]. Another study on diabetic and nondiabetic subjects 
showed significant differences in FPG level between males and 
females [15]. In this study, significant differences (p≤0.001) between 
males and females were observed in the BMI, though the BMI values 
were higher in the females. This is consistent with the idea that females 
generally tend to be more obese compared to males [16]. Several studies 
support this idea, noting that females with diabetes have a higher BMI 
compared to males with diabetes. On the other hand, the male muscles 
generally have less fat compared to the female muscles [17].
There are significant differences in TC and HDL. Females with diabetes 
tend to have a higher TC than males but females also have higher HDL 
values. However, HDL has cardioprotective properties compared to 
other fats [18]. The TC mean values in the females observed in this 
study were higher than that of males, this finding consistent with 
other research studies that stated women who have impaired glucose 
tolerance and diabetes mellitus have a higher relative risk of dying due 
to CVD compared to males with diabetes [19].




30–39 (n=19) Mean±SD 40–49 (n=68) Mean±SD 50–59 (n=90) Mean±SD ≥60 (n=61) Mean±SD
TC 196.91±36.83 206.68±36.63 213.82±40.38 208.03±45.43 0.317
TG 132.63±65.21 132.62±65.00 152.86±74.51 160.43±117.06 0.278
LDL 125.13±26.17 129.59±30.91 132.82±31.51 128.48±39.21 0.671
HDL 48.38±6.68 51.05±12.47 50.02±12.21 50.99±12.61 0.940
Table 3: Lipid profile in different sex
Lipid profiles Sex p
Male Female
TC 201.93±39.80 211.47±40.55 0.039*
TG 166.87±115.48 140.39±69.83 0.232
LDL 124.79±31.02 132.11±33.57 0.059
HDL 44.53±11.29 52.56±11.56 0.000*
*p<0.05. TC: Total cholesterol, TG: Triglyceride, LDL: Low-density lipoprotein, 
HDL: High-density lipoprotein
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Levels of lipid profiles based on age group indicate that age does not 
affect the lipid profile of patients with diabetes. Research on other 
patients with diabetes showed that the relationship between the age 
of diabetic subjects with elevated TC, HDL, and LDL values significantly 
had a negative correlation with a very low correlation coefficient [20]. 
Another study in elderly subjects showed that HDL level is not 
correlated with age [21].
The most common pattern of dyslipidemia among the subjects in this 
study was combined dyslipidemia. Patients with diabetes tend to have 
high triglycerides, an abnormal blood lipid profile consisting of slightly 
elevated low-density lipoprotein cholesterol (LDL-C), and moderately 
decreased high-density lipoprotein cholesterol (HDL-C) [7]. The 
condition is called atherogenic dyslipidemia and is commonly found 
in patients with obesity, metabolic syndrome, insulin resistance, and 
T2DM. It is also an important marker of increased CVD risk [22].
The numbers of patients with diabetes with HDL ≤40 mg/dL were not 
as much as other lipid abnormalities. In the atherogenesis process, 
LDL has the most important role while HDL works to reduce the risk. 
HDL serves to facilitate the excess of cholesterol efflux from cells in the 
periphery and turning back the cholesterol to the liver for excretion 
into bile. HDL may also bring enzymes that further can reduce oxidized 
lipids [23]. Thus, inadequate levels of HDL-C are related to more 
atherogenic forms of LDL and it commonly seen in T2DM, foil the natural 
homeostatic process, and contribute to atherogenesis [23]. HDL mean 
levels in this study bat various age levels or different sex were above 
the standard level (40 mg/dL). Therefore, it may be considered that the 
subjects in this study have some protection against the formation of 
atherogenic dyslipidemia.
The OR shows that being overweight is the best predictor of the 
incidence of dyslipidemia in diabetes because it can significantly 
increase the risk of abnormalities in TC by 2280 times, TG by 
2115 times, and LDL by 1,775 times compared to the values in normal-
weight people. Based on data from the WHO in 2016, the prevalence 
of overweight in Indonesia was 24.4% (male 20.7% and female 
28.1) [24]. The prevalence of overweight in female was higher than 
males, which is consistent with the results of this study. The selection 
of overweight as a limitation of BMI in this study is based on the high 
prevalence of overweight in Indonesia compared to the prevalence of 
obesity (5.7%). Overweight and obesity are one of the main causes 
of metabolic syndrome that includes insulin resistance, T2DM, and 
dyslipidemia, all of which are also risk factor for CVD [25]. Another 
study suggests that overweight school children were 2.4–7.1 times 
more likely to have elevated TC, LDL cholesterol, and TG compared to 
normal weight school children [26]. Moreover, overweight adolescents 
who remained overweight in adulthood were 2.4, 3, and 8 times more 
likely to have abnormal LDL cholesterol, TG, and HDL cholesterol 
concentrations than those who remain lean [27].
Hypertension can increase the risk of TC abnormalities by 2.666 and 
LDL by 2.400 times higher than in subjects with normal BP. Research 
on working-age Japanese males showed that there is a link between 
hypertension and increased levels of TC, LDL, and non-HDL [28]. 
Another study conducted in Bangladesh using T2DM patients showed a 
link between hypertension and an increased risk of abnormal TC levels 
by 1.50 and HDL by 1.67 times higher [29]. Poor glycemic control can 
increase the risk of abnormalities 2.176 times higher than in subjects 
with good glycemic control. Glycemic control can be used as a predictor 
of the incidence of dyslipidemia [29].
The major limitation of the present study is that the data used were 
restricted to the Bogor area only. As such, it cannot represent the overall 
Indonesian situation. With Indonesia being the biggest archipelago 
country with various tribes and cultural customs, follow-up research 
studies that utilize larger data are needed to establish the prevalence 
rate in the whole of Indonesia.
CONCLUSION
Based on the results of this study, we can conclude that in T2DM 
patients, sex affects the TC and HDL level, whereas age grouping did not 
show significant differences in any lipid profiles. Poor glycemic control, 
hypertension, and overweight may serve as predictors of dyslipidemia 
in T2DM.
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